Suppr超能文献

超声引导下经皮胸膜针刺活检:何种患者选用何种穿刺针——一项前瞻性随机研究

Ultrasound-Guided Pleural Needle Biopsy Which Needle for Which Patient: A Prospective Randomized Study.

作者信息

Çelik Emre, Metintaş Muzaffer, Ak Güntülü, Yıldırım Hüseyin, Dündar Emine, Aydın Nevin, Metintaş Selma

机构信息

Department of Chest Diseases, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.

Lung and Pleural Cancers Research and Clinical Center, Eskişehir Osmangazi University, Eskişehir, Türkiye.

出版信息

Balkan Med J. 2025 Jul 1;42(4):321-328. doi: 10.4274/balkanmedj.galenos.2025.2025-4-90.

Abstract

BACKGROUND

Given the growing incidence of pleural effusions and the limited availability of medical thoracoscopy (MT) in clinical practice, ultrasound (US)-guided pleural needle biopsies using Abrams or cutting needles are increasingly being used for the histopathological diagnosis of pleural diseases.

AIMS

To assessed the diagnostic yield and safety of US-guided Abrams and cutting needles to determine the optimal needle type for specific clinical situations.

STUDY DESIGN

Prospective randomized study.

METHODS

The study included 174 patients with undiagnosed pleural effusion requiring histopathological evaluation. Patients were randomized into two arms: those who underwent US-guided cutting needle biopsy (US-CNPB) and those who underwent US-guided Abrams needle biopsy (US-ANPB).

RESULTS

The US-CNPB group exhibited a false-negative rate of 36.9% and diagnostic accuracy of 63.0%. compared to 21.3% and 78.7% in the US-ANPB group, with significant differences between the groups ( = 0.036 and 0.045, respectively). In patients with pleural thickening < 1 cm or absent on US, US-CNPB exhibited 55.2% diagnostic accuracy and a negative likelihood ratio (-LR) of 0.57. For US-ANPB, the corresponding rates were 77.3% and 0.32. The difference in diagnostic accuracy between the two groups was significant ( = 0.009). In patients with pleural thickening ≥ 1 cm, the diagnostic accuracy of US-CNPB was 93.3% and 88.9% for US-ANPB, with no significant difference between the groups. The corresponding -LR values were 0.08 and 0.17. In patients with pleural thickening < 1 cm, four major bleeding events (6.9%) occurred in the US-CNPB group. No deaths were reported in this study.

CONCLUSION

US-CNPB should be preferred in patients with pleural thickness ≥ 1 cm on US. MT is recommended for patients with pleural thickening < 1 cm or those presenting with pleural effusion without pleural thickening. However, in the absence of MT, US-ANPB is the preferred alternative because of its superior diagnostic accuracy and procedural safety.

摘要

背景

鉴于胸腔积液的发病率不断上升,且在临床实践中医疗胸腔镜检查(MT)的可及性有限,使用艾布拉姆斯针或切割针在超声(US)引导下进行胸膜针刺活检越来越多地用于胸膜疾病的组织病理学诊断。

目的

评估超声引导下艾布拉姆斯针和切割针的诊断率及安全性,以确定针对特定临床情况的最佳针型。

研究设计

前瞻性随机研究。

方法

该研究纳入了174例需要进行组织病理学评估的未确诊胸腔积液患者。患者被随机分为两组:接受超声引导下切割针活检(US-CNPB)的患者和接受超声引导下艾布拉姆斯针活检(US-ANPB)的患者。

结果

US-CNPB组的假阴性率为36.9%,诊断准确率为63.0%。相比之下,US-ANPB组分别为21.3%和78.7%,两组之间存在显著差异(分别为P = 0.036和0.045)。在超声显示胸膜增厚<1 cm或无胸膜增厚的患者中,US-CNPB的诊断准确率为55.2%,阴性似然比(-LR)为0.57。对于US-ANPB,相应的比率分别为77.3%和0.32。两组之间的诊断准确率差异显著(P = 0.009)。在胸膜增厚≥1 cm的患者中,US-CNPB的诊断准确率为93.3%,US-ANPB为88.9%,两组之间无显著差异。相应的-LR值分别为0.08和0.17。在胸膜增厚<1 cm的患者中,US-CNPB组发生了4例严重出血事件(6.9%)。本研究中未报告死亡病例。

结论

对于超声显示胸膜厚度≥1 cm的患者,应首选US-CNPB。对于胸膜增厚<1 cm或有胸腔积液但无胸膜增厚的患者,建议进行MT。然而,在没有MT的情况下,由于其更高的诊断准确率和操作安全性,US-ANPB是首选的替代方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验